The 7 most recent market catalysts affecting $XMTR, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 24, 2026
Corporate Catalyst
Neutral
Impact 65
JP Morgan Assumes Xometry at Overweight, Announces Price Target of $120
JP Morgan analyst Bryan Smilek assumed coverage of Xometry (XMTR) with an Overweight rating and a $120 price target. This is a significant positive development for Xometry as a maj…
Aug 20, 2026
Corporate Catalyst
Neutral
Impact 65
Rosenblatt Initiates Coverage On Xometry with Buy Rating, Announces Price Target of $110
Rosenblatt analyst Scott Devitt initiated coverage on Xometry (XMTR) with a 'Buy' rating and a price target of $110. This is a positive development for Xometry as new analyst cover…
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 55
Citigroup Maintains Buy on Xometry, Raises Price Target to $110
Citigroup's analyst Ronald Josey has maintained a 'Buy' rating on Xometry and raised its price target from $98 to $110. This action signals continued confidence in Xometry's busine…
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 65
Cantor Fitzgerald Maintains Overweight on Xometry, Raises Price Target to $110
Cantor Fitzgerald analyst Troy Jensen has maintained an 'Overweight' rating on Xometry (XMTR) and significantly raised the price target from $85 to $110. This upgrade signals incre…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 85
Xometry shares are trading higher after the company reported better-than-expected Q2 sales results and issued Q3 sales guidance above estimates.
This headline is a significant corporate catalyst for Xometry, directly impacting its stock price positively due to better-than-expected financial results and strong forward guidan…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 75
Xometry Q2 Adj. EPS $0.16, Inline, Sales $229.280M Beat $215.137M Estimate
Xometry's Q2 earnings report shows a mixed but generally positive picture. While adjusted EPS met expectations, the substantial beat on sales, coupled with a 41.05% year-over-year …
Jul 16, 2026
Corporate Catalyst
Neutral
Impact 65
Wedbush Assumes Xometry at Outperform, Announces Price Target of $126
Wedbush analyst Ygal Arounian initiated coverage on Xometry (XMTR) with an 'Outperform' rating and a $126 price target. This is a positive development for Xometry as it signals inc…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.